3D Printing Recognized as Reimbursable Method for Prosthetic Fabrication in the U.S.
3D printing has been officially recognized as a reimbursable fabrication method for prosthetic devices under Medicare, marking a key regulatory milestone for digital manufacturing in healthcare. The decision was issued by the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) and the Pricing Data Analysis and Coding (PDAC) contractors, which manage Medicare billing, coverage, and classification codes for DME. It extends the 2024 ruling that acknowledged additive manufacturing for orthotic devices, meaning 3D printing is now formally recognized across the entire orthotics and prosthetics (O&P) sector.



